Organon & Co | OGN - 전 세금 이익

주가
8.83
매일 변경
1.92 27.79%
매월
37.97%
매년
-20.91%
Q2 예상
8.59




전 세금 이익 변화 날짜
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Celltrion KRW 14.6B 180.89B 2025-06
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Divis Laboratories Ltd INR 8.54B 580M 2025-12
Gilead Sciences USD 3.64B 1.21B 2025-09
Glaxosmithkline GBP 2.46B 569M 2025-09
Kangmei Pharma CNY 2.07M 13.77M 2025-09
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
Medical Developments International AUD -149K 466K 2025-06
Merck USD 6.74B 22M 2025-09
Neuren Pharmaceuticals AUD 9.86M 161.24M 2025-06
Novartis USD 5.17B 637M 2025-09
Organigram Holdings CAD -41.72M 25.52M 2025-09
Organon & Co USD 243M 14M 2025-09
Pharma Mar EUR 40.2M 44.28M 2025-12
Qiagen NV USD 134.73M 7.91M 2025-09
Sartorius EUR 85M 14.1M 2025-09
Tilray USD -39.96M 39.19M 2025-09
Zealand Pharma A/S -406.5M 39.77M 2025-12